NYSE:MET - Metlife Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$44.86 +1.06 (+2.42 %)
(As of 02/15/2019 04:00 PM ET)
Previous Close$44.86
Today's Range$44.23 - $45.02
52-Week Range$37.76 - $48.92
Volume6.03 million shs
Average Volume5.65 million shs
Market Capitalization$44.27 billion
P/E Ratio8.32
Dividend Yield3.84%
Beta1.2
MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, tort settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers automobile, homeowners', and personal excess liability, as well as small business owners' property, liability, and business interruption insurance products. Further, it provides fixed annuities and pension products; medical and credit insurance products; variable, universal, term, endowment, and whole life insurance products; variable, and fixed and indexed-linked annuities; and protection against costs of long-term health care services. MetLife, Inc. has a strategic alliance with Ernst & Young LLP. The company serves individuals, corporations and their employees, and other institutions through independent agents, property and casualty specialists, sales forces, sales teams and relationship managers, and other organizations, as well as through career agency, bancassurance, direct marketing, brokerage, and other third-party distribution and e-commerce channels. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.

Receive MET News and Ratings via Email

Sign-up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Life insurance
Sub-IndustryLife & Health Insurance
SectorFinance
CUSIP59156R10
Phone212-578-9500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$67.94 billion
Cash Flow$4.5405 per share
Book Value$53.66 per share

Profitability

Net Income$5.12 billion

Miscellaneous

Employees49,000
Market Cap$44.27 billion
OptionableOptionable

Metlife (NYSE:MET) Frequently Asked Questions

What is Metlife's stock symbol?

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

How often does Metlife pay dividends? What is the dividend yield for Metlife?

Metlife declared a quarterly dividend on Monday, January 7th. Shareholders of record on Tuesday, February 5th will be paid a dividend of $0.42 per share on Wednesday, March 13th. This represents a $1.68 dividend on an annualized basis and a yield of 3.74%. The ex-dividend date of this dividend is Monday, February 4th. View Metlife's Dividend History.

How will Metlife's stock buyback program work?

Metlife declared that its Board of Directors has authorized a share buyback plan on Thursday, November 1st 2018, which allows the company to buyback $2,000,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to reacquire up to 4.6% of its stock through open market purchases. Stock buyback plans are typically an indication that the company's management believes its stock is undervalued.

How were Metlife's earnings last quarter?

Metlife Inc (NYSE:MET) posted its quarterly earnings data on Wednesday, February, 6th. The financial services provider reported $1.35 earnings per share for the quarter, topping the consensus estimate of $1.30 by $0.05. The financial services provider earned $15.40 billion during the quarter, compared to analyst estimates of $15.84 billion. Metlife had a return on equity of 10.24% and a net margin of 7.53%. The firm's quarterly revenue was up .0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.64 EPS. View Metlife's Earnings History.

When is Metlife's next earnings date?

Metlife is scheduled to release their next quarterly earnings announcement on Wednesday, May 1st 2019. View Earnings Estimates for Metlife.

What price target have analysts set for MET?

14 analysts have issued 1 year price objectives for Metlife's shares. Their forecasts range from $44.06 to $63.00. On average, they expect Metlife's stock price to reach $53.5050 in the next year. This suggests a possible upside of 19.3% from the stock's current price. View Analyst Price Targets for Metlife.

What is the consensus analysts' recommendation for Metlife?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 5 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Metlife.

What are Wall Street analysts saying about Metlife stock?

Here are some recent quotes from research analysts about Metlife stock:
  • 1. According to Zacks Investment Research, "MetLife has been performing significantly well on the back of prudent underwriting and expense management. Its efforts to streamline business, only to focus on core business are really impressive. Its revenues grew in 2017 and first half of 2018 after declining for two years and the trend is likely to continue. Its strong international operations and disciplined capital management should drive long-term growth. Its shares have outperformed its industry in six months time. However, the company’s exposure to catastrophe losses and investment in efficiency programs will put pressure on margins.  Shares of the company have lost in a year’s time, slightly narrower than its industry’s decline." (1/21/2019)
  • 2. Wells Fargo & Co analysts commented, "We attended in Tokyo. The company provided context around its Asian business, which represents 25% of its earnings ($1.2 billion in 2017) but is expected to grow in the double-digits. Of its Asian business about 75% of its earnings comes from Japan. MET spoke optimistically about: (1) the growth prospects of the region due to its low insurance penetration, GDP growth of 4.8% in the countries MET operates in, and an aging population, and (2) its commitment to sustainable growth in cash from its Asian business (60% of its GAAP earnings are being taken out as dividends). The meeting also gave us a chance to hear from Kishore Ponnavolu, who took over as head of MET’s Asian business at the start of September. We are not changing our EPS estimates or price target at this time and do not expect a material movement in the shares following the meeting." (9/27/2018)

Has Metlife been receiving favorable news coverage?

News coverage about MET stock has trended neutral on Saturday, according to InfoTrie. The research firm scores the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Metlife earned a news sentiment score of 0.2 on InfoTrie's scale. They also assigned media stories about the financial services provider a news buzz of 9.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the next few days.

Who are some of Metlife's key competitors?

Who are Metlife's key executives?

Metlife's management team includes the folowing people:
  • Mr. Steven Albert Kandarian, Chairman, Pres & CEO (Age 66)
  • Mr. Martin J. Lippert, Exec. VP and Head of Global Technology & Operations (Age 59)
  • Mr. Steven Jeffrey Goulart, Exec. VP & Chief Investment Officer (Age 60)
  • Mr. Michel A. Khalaf, Pres of U.S. Bus. & EMEA (Age 55)
  • Mr. John Dennis McCallion, Exec. VP & CFO (Age 45)

Who are Metlife's major shareholders?

Metlife's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.35%), Massachusetts Financial Services Co. MA (2.25%), Bank of New York Mellon Corp (1.42%), Oregon Public Employees Retirement Fund (1.30%), Geode Capital Management LLC (1.26%) and Northern Trust Corp (1.16%). Company insiders that own Metlife stock include Carlos M Gutierrez, Christopher G Townsend, Gerald L Hassell, James M Kilts, John D Mccallion, Steven A Kandarian and Steven J Goulart. View Institutional Ownership Trends for Metlife.

Which major investors are selling Metlife stock?

MET stock was sold by a variety of institutional investors in the last quarter, including Schafer Cullen Capital Management Inc, Epoch Investment Partners Inc., Massachusetts Financial Services Co. MA, Cullen Capital Management LLC, KBC Group NV, Poplar Forest Capital LLC, Oppenheimer Asset Management Inc. and WBI Investments Inc.. Company insiders that have sold Metlife company stock in the last year include John D Mccallion, Steven A Kandarian and Steven J Goulart. View Insider Buying and Selling for Metlife.

Which major investors are buying Metlife stock?

MET stock was purchased by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, MERIAN GLOBAL INVESTORS UK Ltd, Canada Pension Plan Investment Board, Bank of New York Mellon Corp, Northern Trust Corp, Geode Capital Management LLC, BlackRock Inc. and Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp. Company insiders that have bought Metlife stock in the last two years include Carlos M Gutierrez, Gerald L Hassell and James M Kilts. View Insider Buying and Selling for Metlife.

How do I buy shares of Metlife?

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Metlife's stock price today?

One share of MET stock can currently be purchased for approximately $44.86.

How big of a company is Metlife?

Metlife has a market capitalization of $44.27 billion and generates $67.94 billion in revenue each year. The financial services provider earns $5.12 billion in net income (profit) each year or $5.39 on an earnings per share basis. Metlife employs 49,000 workers across the globe.

What is Metlife's official website?

The official website for Metlife is http://www.metlife.com.

How can I contact Metlife?

Metlife's mailing address is 200 PARK AVENUE, NEW YORK NY, 10166. The financial services provider can be reached via phone at 212-578-9500.


MarketBeat Community Rating for Metlife (NYSE MET)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  765 (Vote Outperform)
Underperform Votes:  486 (Vote Underperform)
Total Votes:  1,251
MarketBeat's community ratings are surveys of what our community members think about Metlife and other stocks. Vote "Outperform" if you believe MET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MET will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel